New Approaches for Activating Silent Biogenetic Gene Clusters in Marine Microorganisms
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 May 2015) | Viewed by 136168
Special Issue Editors
Interests: marine natural products, marine medicines, chemical ecology
Special Issues, Collections and Topics in MDPI journals
Interests: life aquatic
Special Issue Information
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine microorganisms
- marine fungi
- marine bacteria
- natural products
- co-cultivation
- silent biogenetic gene clusters
- OSMAC
- Epigenetic modifiers
- HDAC
- DNMT
- SAHA
- 5-azacytidine
- valproic acid